Please assess the completion status of the following clinical trial:

Trial Title: Does in Vivo Culture of Pre-cleavage Stage Embryo Reduce the Incidence of Aneuploidy?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed Informed Consent by the subject and her partner~* Women, aged between 18 and 38 years (up to 38th birthday)~* ≤ 2 previous stimulation cycles~* Routinely measured hormonal levels within normal range (i.e. FSH, LH, E2, PRL)~* No uterine or ovarian anatomical abnormalities and/or alterations that would compromise device delivery or function in the uterus as demonstrated by ultrasound and trial insertion~* 19 ≤ BMI ≤ 29 kg/m2~Exclusion Criteria:~* History of previous moderate or severe ovarian hyperstimulation syndrome (OHSS)~* Severe endometriosis~* Any active infection that would contraindicate ART, at the discretion of the investigator~* Severe male factor in the partner (cryptozoospermia or non-obstructive azoospermia)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 38 Years
- Healthy Volunteers: t

Study Arms:
- sibling oocytes in vivo (Type: EXPERIMENTAL): randomized oocytes assigned to in vivo culture
- sibling oocyte in vitro (Type: ACTIVE_COMPARATOR): randomized oocytes assigned to in vitro culture

Based on this trial design, predict the completion outcome and termination type (if applicable).